Parkinson’s disease is a long-term brain condition that affects movement, thinking, and daily life. It often develops slowly over many years.
People with Parkinson’s may notice shaking, stiffness, slow movement, and trouble with balance. These symptoms happen because certain brain cells are damaged or lost over time.
One of the key systems affected in Parkinson’s disease is the dopamine system. Dopamine is a chemical that helps brain cells send signals to each other. It plays an important role in controlling movement, motivation, and decision-making.
When dopamine-producing cells stop working properly, the brain cannot send clear signals, and movement becomes difficult.
Now, scientists at Stanford Medicine have made an exciting discovery that may help protect and even repair these damaged brain cells. Their study, published in the journal Science Signaling, was carried out in mice and offers new hope for future treatments.
The research focuses on a specific form of Parkinson’s disease that is linked to a genetic mutation. In these cases, an enzyme called LRRK2 becomes too active. Enzymes are proteins that help control chemical reactions in the body. When LRRK2 is overactive, it interferes with how brain cells communicate with each other.
This communication problem is especially important in the dopamine system. When signals are disrupted, brain cells cannot work together properly, which leads to the symptoms of Parkinson’s disease.
The research team, led by Dr. Suzanne Pfeffer, wanted to find out if blocking this overactive enzyme could help restore normal brain function. To do this, they used a special compound called MLi-2. This compound attaches to the LRRK2 enzyme and reduces its activity.
Inside the brain, communication between cells depends on tiny structures called primary cilia. These structures act like small antennas, helping cells send and receive signals. In a healthy brain, dopamine-producing neurons send messages to another area called the striatum using these cilia.
However, when LRRK2 is too active, many brain cells lose their cilia. Without these structures, the cells cannot receive important signals. One of these signals comes from a protein known as “sonic hedgehog.” This protein helps trigger the production of protective substances that keep brain cells alive.
Without cilia, this protective system breaks down. As a result, fewer protective proteins are made, and more brain cells are at risk of damage and death.
At first, the researchers gave the mice with the Parkinson’s mutation the inhibitor drug for two weeks. Unfortunately, this short treatment did not show any clear improvement. But the team did not stop there.
They were inspired by another study that showed brain cells can grow and shrink their cilia over time, especially in relation to sleep patterns. Based on this idea, the scientists decided to try a longer treatment period.
This time, they treated the mice for three months. The results were very promising. After this longer treatment, the brain cells in the affected mice began to look more like healthy cells. The primary cilia had grown back, allowing signals to pass through again.
With communication restored, the protective system was also reactivated. The researchers even saw signs that damaged neurons were beginning to recover. This suggests that the treatment may not only slow the disease but also improve brain function.
Dr. Pfeffer explained that this discovery is especially important because Parkinson’s disease often begins many years before symptoms appear. Early warning signs can include loss of smell, constipation, and sleep problems. These signs can appear up to 15 years before movement problems begin.
If doctors can identify people at risk early, treatments like this could be used before serious damage occurs. This could delay or even prevent the onset of symptoms.
The research team now plans to explore whether this approach can help people with other types of Parkinson’s disease, not just those with the specific genetic mutation. This is important because most cases of Parkinson’s are not linked to a single gene.
There are already clinical trials underway to test drugs that target the LRRK2 enzyme in humans. These trials will help determine whether the findings from this study can be applied to real patients.
This discovery offers new hope for people affected by Parkinson’s disease. It shows that it may be possible to repair damaged brain systems and restore lost communication between cells.
While more research is needed, this study is an important step forward. It highlights the power of understanding how diseases work at the smallest level and using that knowledge to develop better treatments.
In simple terms, scientists are getting closer to not just managing Parkinson’s disease, but possibly slowing it down or even reversing some of its early effects.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more information about brain health, please see recent studies that blueberry supplements may prevent cognitive decline, and results showing Plant-based diets could protect cognitive health from air pollution.
Copyright © 2026 Knowridge Science Report. All rights reserved.
